Target Corp. has agreed to sell its pharmacy and clinic businesses to the drugstore chain CVS Health Corp. for about $1.9 billion in a deal that combines the resources of two retailers seeking to polish their health care reputations.
The Obama administration could write a new regulation. Congress could pass a short law. States could run a low-cost exchange. But the politics might require all parties to let the tax credits die while they try to pin the blame on the other side.
Axovant Sciences Ltd., a company without a finished product or a dime of sales, has an almost $3 billion valuation after its public-market debut. The IPO shows the staggering potential for any company that can develop a successful Alzheimer’s treatment.
Anthem Blue Cross and Blue Shield has added St. Vincent Health to the “narrow network” of health care providers it uses for Obamacare plans.
The National Labor Relations Board declined to dismiss charges that IU Health broke the law by firing one nurse and disciplining another who were involved in trying to form a union at Methodist Hospital.
Dr. Kent Brantly was awarded the Dr. Nathan Davis International Award in Medicine from the American Medical Association for his service in Liberia during last summer’s Ebola outbreak.
Progress in reducing smoking is undeniable, but money to accelerate the decline is falling even faster.
Millions of people will be able to see a doctor on their smartphones or laptops for everyday ailments once the nation's largest drugstore chain and two major insurers expand a budding push into virtual health care.
A medical software company is notifying patients of the health care providers it serves—including Franciscan St. Francis Health in Indianapolis—that their private information may have been exposed when its networks were hacked.
Eli Lilly stock rose 5.4 percent per share on Tuesday, its biggest daily increase since March 2009, after Elanco President Jeffrey Simmons was asked if Lilly might one day shed the unit in an initial public offering.
Humana Inc. has pulled out of a major health care conference and said it will not comment on rumors of a merger, actions that will likely fuel Wall Street speculation that the insurer is part of a developing deal. Anthem Inc. is a possible suitor.
Indianapolis-based Eli Lilly and Co. plans to introduce its version of Sanofi’s Lantus insulin for diabetes in Europe in the third quarter, said Enrique Conterno, the president of Lilly Diabetes.
The organization has come up with a new way to help its small-business members while giving them a better deal on employee benefits.
An experimental pill to treat low sexual desire in women moved closer to becoming the first such drug to be sold in the U.S. after regulatory advisers backed its approval.
The new version of the Healthy Indiana Plan, backed by Obamacare funding, has enrolled 229,000 new participants in four months without breaking stride.
The Indianapolis-based health insurer announced Tuesday that it will pay upfront the $2,500 annual cost of a business or health care degree from College for America, which provides online programs for adults.
Dozens of health insurers say higher-than-expected care costs and other expenses blindsided them this year, and they're going to have to hike premiums for individual policies well-beyond 10 percent for 2016.
Wall Street analysts say a purchase of Louisville-based Humana Inc., which reportedly has put itself up for sale, would by Indianapolis-based Anthem. An Anthem-Humana marriage would be the biggest merger in the history of U.S. health insurance.
Thousands of Indiana children who raised and doted on chickens, turkeys and other poultry for 4-H projects are feeling the sting of a statewide ban on bird shows aimed at preventing the spread of a bird flu.
It took $394,000 to rank in the top 1 percent of U.S. earners in 2013. And more than 100 of the Indiana contingent in that exclusive club were physicians employed by one of the four major hospital systems that operate in the Indianapolis area.
